We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Drug Developers Ponder Use of Highly Concentrated Protein Nanoparticles

By LabMedica International staff writers
Posted on 13 Feb 2012
Print article
Drug developers have shown that nanoparticles comprised of extremely high concentrations of protein molecules maintain the stability and metabolic function of the proteins until they are injected or diluted.

Investigators at the University of Texas (Austin, USA) have been experimenting with protein nanoparticles for the last several years. In the current study, which was published in the January 19, 2012, online edition of the journal ACS Nano, they created highly concentrated antibody dispersions (up to 260 mg/mL) comprising dense equilibrium nanoclusters of protein (monoclonal antibody 1B7, polyclonal sheep immunoglobulin G, and bovine serum albumin) molecules. The nanoclusters were formed by lowering the pH of the protein solution and adding the sugar trehalose as a co-solute, which strengthened the short-ranged attraction between protein molecules.

The extremely concentrated environment within the nanoclusters (700 mg/mL) provided conformational stability to the protein through a novel self-crowding mechanism, as shown by computer simulation, while the primarily repulsive nanocluster interactions resulted in colloidally stable, transparent dispersions.

Upon dilution of the dispersions in vitro, the clusters rapidly dissociated into fully active protein monomers as was shown by biophysical analysis and sensitive biological assays. In vivo subcutaneous injection into mice resulted in pharmacokinetics indistinguishable from that of a standard antibody solution.

“This general physical concept for forming highly concentrated, yet stable, protein dispersions is a major new direction in protein science,” said first author Dr. Keith P. Johnston, professor of chemical engineering at the University of Texas. “We believe this discovery of a new highly concentrated form of proteins – clusters of individual protein molecules – is a disruptive innovation that could transform how we fight diseases. It required integration of challenging contributions in fundamental science and engineering from three of our chemical engineering research groups.”

Related Links:

University of Texas


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Myeloperoxidase Assay
IDK MPO ELISA
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.